A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)

被引：0
|
作者：
Yang, E. S. [1 ]
Deutsch, E. [2 ]
Mehmet, A. [3 ]
Fayette, J. [4 ]
Nabell, L. [5 ]
Spencer, S. A. [1 ]
Dobelbower, M. C. [1 ]
Willey, C. D. [1 ]
Bonner, J. A. [1 ]
Wang, X. [6 ]
Lin, A. [6 ]
William, W. N. [7 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Paris Saclay, Gustave Roussy, Villejuif, France
[3] MD Anderson, Houston, TX USA
[4] Univ Lyon, Ctr Leon Berard, Ctr Canc, Clin Oncol, Lyon, France
[5] Univ Alabama Birmingham, Ctr Comprehens Canc, Clin Studies Unit, Birmingham, AL 35294 USA
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
201
引用
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [41] A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Razak, Albiruni R. Abdul
    Wang, Hung-Ming
    Chang, Jang-Yang
    Ahn, Myung-Ju
    Munster, Pamela
    Blumenschein Jr, George
    Solomon, Benjamin
    Lim, Darren Wan-Teck
    Hong, Ruey-Long
    Pfister, David
    Saba, Nabil F.
    Lee, Se-Hoon
    van Herpen, Carla
    Quadt, Cornelia
    Bootle, Douglas
    Blumenstein, Lars
    Demanse, David
    Delord, Jean-Pierre
    [J]. TARGETED ONCOLOGY, 2023, 18 (06) : 853 - 868
  • [42] A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Albiruni R. Abdul Razak
    Hung-Ming Wang
    Jang-Yang Chang
    Myung-Ju Ahn
    Pamela Munster
    George Blumenschein
    Benjamin Solomon
    Darren Wan-Teck Lim
    Ruey-Long Hong
    David Pfister
    Nabil F. Saba
    Se-Hoon Lee
    Carla van Herpen
    Cornelia Quadt
    Douglas Bootle
    Lars Blumenstein
    David Demanse
    Jean-Pierre Delord
    [J]. Targeted Oncology, 2023, 18 : 853 - 868
  • [43] KEYNOTE-412: Phase 3 trial of pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Yen, C-J.
    Machiels, J-P.
    Licitra, L.
    Rischin, D.
    Waldron, J.
    Burtness, B.
    Gregoire, V.
    Tao, Y.
    Yorio, J.
    Aksoy, S.
    Ikeda, S.
    Hong, R-L.
    Ge, J. Y.
    Brown, H.
    Bidadi, B.
    Siu, L.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [44] Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Machiels, J-P.
    Yen, C-J.
    Licitra, L.
    Rischin, D.
    Waldron, J.
    Burtness, B.
    Gregoire, V.
    Tao, Y. G.
    Yorio, J.
    Aksoy, S.
    Ikeda, S.
    Hong, R-L.
    Ge, J. Y.
    Brown, H.
    Bidadi, B.
    Siu, L.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [45] A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
    Caponigro, Francesco
    Romano, Carmen
    Milano, Amalia
    Solla, Raffaele
    Franchin, Giovanni
    Adamo, Vincenzo
    Mari, Ettore
    Morrica, Brunello
    Pepe, Stefano
    [J]. ANTI-CANCER DRUGS, 2008, 19 (07) : 739 - 744
  • [46] Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
    Aguilar-Ponce, JL
    Granados-García, M
    Villavicencio, V
    Poitevin-Chacón, A
    Green, D
    Dueñas-González, A
    Herrera-Gómez, A
    Luna-Ortiz, K
    Alvarado, A
    Martínez-Said, H
    Castillo-Henkel, C
    Segura-Pacheco, B
    De la Garza, J
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (02) : 301 - 306
  • [47] Maturing toxicity and outcomes of a phase I trial of concurrent, daily getitinib and radiation or chemoradiation for patients with locally advanced squamous cell carcinoma of the head and neck (LASCCHN)
    Raben, D
    Chen, C
    Eckhardt, GS
    Kane, M
    Song, JI
    Bemis, L
    Varella-Garcia, M
    Brualdi, L
    Raben, A
    Hu, K
    Quon, H
    Dancey, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S370 - S371
  • [48] Long-term Results of a Phase 1/2 Trial of the Addition of Celecoxib to Chemoradiation Therapy for Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
    McDonald, A.
    Ove, R.
    Bonner, J. A.
    Nabell, L. M.
    Caroll, W. R.
    Al-Naief, N. Said
    Brandwein-Gensler, M. S.
    Spencer, S. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E345 - E345
  • [49] A prospective randomised controlled trial of concurrent chemoradiation versus concurrent chemoradiation along with gefitinib in locally advanced squamous cell carcinoma of head and neck
    Bhattacharya, Biswamit
    Pal, Santanu
    Chattopadhyay, Bitoti
    Adhikary, Shyam Sundar
    Basu, Joydeep
    Ghosh, Tanmoy
    [J]. CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (02): : 146 - 152
  • [50] Phase 2b Randomized Trial Comparing Concurrent Chemoradiation With Weekly Versus 3 Weekly Cisplatinum in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Kumar, R. R.
    Haridas, G.
    Kainickal, C. T.
    Sudha, A. S.
    Rafi, M.
    Raghavan, R.
    Ramadas, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S566 - S566
12345